Eli Lilly ٢٨ أبريل ٢٠٢٦ Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine ‘holy grail’ - BioSpace
Eli Lilly ٢٨ أبريل ٢٠٢٦ Lilly pens $2.2B pact with Bezos-backed Profluent to work on recombinase-based gene editing - Fierce Biotech
Eli Lilly ٢٨ أبريل ٢٠٢٦ Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine - Business Wire
Eli Lilly ٢٧ أبريل ٢٠٢٦ Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs - CNBC
Eli Lilly ٢٧ أبريل ٢٠٢٦ Eli Lilly to buy Ajax Therapeutics for up to $2.3 billion in blood cancer bet - Reuters
Eli Lilly ٢٧ أبريل ٢٠٢٦ Lilly pens $2.3B deal for next-gen JAK inhibitor biotech Ajax - Fierce Biotech
FierceBiotech ٢٤ أبريل ٢٠٢٦ After Lilly’s $7B Kelonia deal, are there any in vivo CAR-T biotechs left to buy?
BioPharma Dive ٢٤ أبريل ٢٠٢٦ Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
FierceBiotech ٢٢ أبريل ٢٠٢٦ Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
Insilico Medicine ٢١ أبريل ٢٠٢٦ Insilico Medicine and Eli Lilly and Company Partner on AI-Driven Drug Discovery - CDO Magazine
BioPharma Dive ١٧ أبريل ٢٠٢٦ Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool